Nantahala Capital Management - AVALO THERAPEUTICS INC ownership

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 33 filers reported holding AVALO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$197,563
-86.0%
556,202
-31.2%
0.02%
-82.4%
Q1 2023$1,415,477
-48.1%
808,844
+49.6%
0.11%
-39.0%
Q4 2022$2,725,016
+49.8%
540,667
-1.3%
0.18%
+50.0%
Q3 2022$1,819,000547,8140.12%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,250,000$444,0000.07%
Nantahala Capital Management 556,202$197,5630.02%
Virtu Financial LLC 32,593$120.00%
Kistler-Tiffany Companies, LLC 2$10.00%
VANGUARD GROUP INC 222,073$78,8800.00%
First Horizon Advisors, Inc. 276$980.00%
UBS Group AG 1,919$6800.00%
OSAIC HOLDINGS, INC. 334$1180.00%
Parallel Advisors, LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 4,127$1,4650.00%
View complete list of AVALO THERAPEUTICS INC shareholders